Biotech
Xaira Therapeutics
Xaira Therapeutics raises $1B Series A at $4B valuation
$1B
Total Raised
Series A
Latest Round
2023
Founded
100+
Employees
San Francisco, CA
1 min read
Quick Facts
Valuation
$4B
Latest Round Size
$1B
Latest Round Date
April 2024
Xaira Therapeutics: Series A Funding Round
Xaira Therapeutics has successfully raised $1B in Series A funding, reaching a valuation of $4B.
Company Overview
AI-powered drug discovery platform
Funding Details
The Series A round was led by Foresite Capital, with participation from ARCH Venture Partners, NEA.
Company Information
- Headquarters: San Francisco, CA
- Founded: 2023
- Employees: 100+
- Category: Biotech
Investment
Xaira Therapeutics plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Foresite Capital: Verified investor in Series A
- ARCH Venture Partners: Verified investor in Series A
- NEA: Verified investor in Series A
Key Investors
Foresite Capital
Lead Investor
Verified investor in Series A
ARCH Venture Partners
Investor
Verified investor in Series A
NEA
Investor
Verified investor in Series A
About the Author
Editorial Team
Curated funding news from verified sources
Related Company Reports
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C
Biotech
Vir Biotechnology
Vir Biotechnology Raises $250M
Clinical-stage immunology company developing treatments for infectious diseases including COVID-19, hepatitis B, and influenza
Sarah Kim
Oct 23, 2025
0 min read•$250M